Two Compounds Discovered that Pave the Way for New Class of AIDS Drug

A team of researchers at the renowned Scripps Research Institute has discovered two new compounds that prove the existence of new binding sites on HIV protease. Associate Professor C. David Stout, senior author of the study, explained “These results open the door to a whole new approach to drug design against HIV protease,” which is an enzyme used by HIV to create new, infectious viral particles.

	E-mail this page			Save to del.icio.us			Digg this